Xuzhou Medical University

• NCT04991662

  Phase 4, Completed, 78 people, 5 Aug 2021

• NCT03756727

  Early phase 1, Status unknown, 110 people, 28 Nov 2018

• NCT03596775

  Early phase 1, Status unknown, 96 people, 24 Jul 2018

• NCT03256071

  Collaborator, Phase 2/3, Status unknown, 90 people, 21 Aug 2017

• Do depressive symptoms predict cognitive function decline in middle-aged and older adults? A three-wave longitudinal study

  27 Aug 2026

• A lyophilized CHA-lateral flow platform for point-of-care detection of miR-106b-5p from L1CAM-Immunocaptured small extracellular vesicles in Alzheimer's disease

  11 Jul 2026

• Senolytic therapy ameliorates high-fat diet-induced hippocampal senescence and cognitive decline in mice

  2024BMS18, D2017007, 25 Mar 2026

• o-Vanillin enhances bone health and fracture healing by inhibiting cellular senescence in aging mice

  XZSYSKF2020004, 30 Dec 2025

• Pyrroloquinoline quinone targets senescent osteoclasts and reduces spinal pain and endplate degeneration in a lumbar spine instability mouse model

  XZSYSKF2020004, 17 Oct 2025

Sources: api.crossref.org